Business Context and Reporting Period
This Form 8-K Current Report was filed by Zimmer Holdings, Inc. (now Zimmer Biomet Holdings, Inc.) on February 23, 2009. The filing reports a corporate governance event: the appointment of a new director to the Board of Directors.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial statements or performance data.
Material Changes
The primary material change reported is the expansion of the Board of Directors. On February 23, 2009, the Board appointed Marc N. Casper as a new director. This appointment increases the total number of Board members to nine. Mr. Casper's term is set to expire at the 2009 annual meeting of stockholders scheduled for May 4.
Guidance, Outlook, and Management Commentary
- Committee Assignments: Mr. Casper has not been appointed to any Board committees at the time of filing, though the Company expects he will be assigned to one or more committees in the future.
- Compensation: As a non-employee director, Mr. Casper will participate in the standard non-employee director compensation arrangements described in the Company's definitive proxy statement filed on March 20, 2008.
- Indemnification: It is expected that Mr. Casper will execute the Company's standard form of non-employee director indemnification agreement.
- Risks and Contingencies: The filing states there are no arrangements or understandings between Mr. Casper and any other persons pursuant to which he was appointed.
Important Facts for Investor Verification
- Verify the specific committee assignments for Marc N. Casper once announced by the Company.
- Review the definitive proxy statement filed on March 20, 2008, to understand the specific compensation structure applicable to Mr. Casper.
- Confirm the date and agenda of the 2009 annual meeting of stockholders scheduled for May 4, where Mr. Casper's term will expire.